Wide Ranks

CYCN

Cyclerion Therapeutics, Inc.

2.16

Top Statistics
Market Cap 5 M Forward PE -1.65 Revenue Growth 0.00 %
Current Ratio 3.68 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 4 M Total Cash Per Share 1.82 Total Debt
Total Debt To Equity Current Ratio 3.68 Book Value Per Share 4.56
All Measures
Short Ratio 78.00 % Message Board Id finmb_561493203 Fax 617 890 6595
Shares Short Prior Month 10754 Return On Equity -1.50 City Cambridge
Uuid dd748c39-0459-359f-9a4f-d9343a16eaf1 Previous Close 1.36 First Trade Date Epoch Utc 1 B
Book Value 4.56 Beta 1.92 Volume 29 M
Price To Book 0.4735 Last Split Date 1 B Fifty Two Week Low 1.27
Total Cash Per Share 1.82 Shares Short Previous Month Date 1 B Max Age 86400
Sand P52 Week Change 0.3133 Net Income To Common -10467000 Short Percent Of Float 0.0087
Implied Shares Outstanding 2 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 4 M Average Volume10days 4 M Total Cash 4 M
Next Fiscal Year End 1 B Held Percent Insiders 0.2190 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 1.36
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.49
Open 2.16 Free Cashflow -6386125 State MA
Dividend Yield 0.00 % Return On Assets -0.4655 Time Zone Short Name EST
Trailing Eps -2.08 Day Low 1.72 Address1 245 First Street, Riverview II
Shares Outstanding 2 M Price Hint 4 Target High Price 0.0000
Website https://www.cyclerion.com 52 Week Change -0.0092 Average Volume 696895
Forward Eps -1.31 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 357.90 % Last Split Factor 1:20 Regular Market Day High 2.34
Is_sp_500 False Profit Margins 0.00 % Fifty Two Week High 5.25
Day High 2.34 Shares Short 14439 Regular Market Open 2.16
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0057 Operating Cashflow -11453000 Currency USD
Time Zone Full Name America/New_York Market Cap 5 M Is_nasdaq_100 False
Zip 02142 Quote Type EQUITY Industry Biotechnology
Long Name Cyclerion Therapeutics, Inc. Regular Market Day Low 1.72 Held Percent Institutions 0.4041
Current Price 2.16 Address2 18th Floor Financial Currency USD
Current Ratio 3.68 Industry Disp Biotechnology Country United States
Float Shares 1 M Two Hundred Day Average 2.82 Enterprise Value 1 M
Forward PE -1.65 Regular Market Volume 29 M Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases.

It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease.

The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.